ReviewCurrent pharmaceutical design2016

Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients.

Bradley J Monk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.